ÂÜÀòÂÒÂ×

Andrew Kelly is an accomplished executive with extensive experience in the food, health, and agriculture sectors, primarily within Australia and New Zealand. Currently serving as Executive Director at BioPacific Partners since 2014, Andrew has been instrumental in connecting global investors with local innovations. Prior to this role, Andrew held directorial positions at Focus Genetics, CoDa Therapeutics, Horizon Science Pty Ltd, and Wool Equities, among others, contributing to advancements in animal genetics, drug development, and health technologies. With a solid foundation in veterinary science, including a PhD from the University of Melbourne, Andrew has shaped commercial strategies and fostered innovation across various organizations, emphasizing both market engagement and technological integration.